Publications by authors named "Arto A Palmu"

Claim this Profile
H
How to improve pertussis vaccination in pregnancy: a European expert review.
Adam Finn, Nicole Guiso, Carl Heinz Wirsing von König, Federico Martinón-Torres, Arto A Palmu

Expert Rev Vaccines· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination against measles-mumps-rubella and rates of non-targeted infectious disease hospitalisations: Nationwide register-based cohort studies in Denmark, Finland, Norway, and Sweden.
Lise Gehrt, Sören Möller, Hélène Englund, Ida Laake, Heta Nieminen, Arto A Palmu

J Infect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Real-Time Surveillance for Serious Adverse Events in a Pragmatic Clinical Trial Using National Registers in Finland.
Tuomo A Nieminen, Arto A Palmu, Raija Auvinen, Sangita Kulathinal, Kari Auranen

Clin Epidemiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect protection in adults ≥18 years of age from pediatric pneumococcal vaccination: a review.
Elmira Flem, Celine Mouawad, Arto A Palmu, Heather Platt, Kelly D Johnson

Expert Rev Vaccines· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study.
Annika Saukkoriipi, Natalie C Silmon de Monerri, Maija Toropainen, Laura Lindholm, Riitta Veijola, Arto A Palmu

Lancet Microbe· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults.
Arto A Palmu, Stephanie Pepin, Ritva K Syrjänen, Karine Mari, Tamala Mallett Moore

Influenza Other Respir Viruses· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe COVID-19.
Nina Ekström, Tuija M Leino, Aapo Juutinen, Toni Lehtonen, Anu Haveri, Arto A Palmu

Vaccines (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022.
Anna Solastie, Tuomo Nieminen, Nina Ekström, Hanna Nohynek, Lasse Lehtonen, Arto A Palmu

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underreporting of SARS-CoV-2 infections during the first wave of the 2020 COVID-19 epidemic in Finland-Bayesian inference based on a series of serological surveys.
Tuomo A Nieminen, Kari Auranen, Sangita Kulathinal, Tommi Härkänen, Merit Melin, Arto A Palmu

PLoS One· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cohort Profile: Childhood morbidity and potential non-specific effects of the childhood vaccination programmes in the Nordic countries (NONSEnse): register-based cohort of children born 1990-2017/2018.
Lise Gehrt, Ida Laake, Hélène Englund, Heta Nieminen, Berit Feiring, Arto A Palmu

BMJ Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of sinus thrombosis with thrombocytopenia-A nation-wide register study.
Petteri Hovi, Arto A Palmu, Tuomo A Nieminen, Miia Artama, Jukka Jokinen

PLoS One· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective nationwide register-based study to evaluate the non-specific effects of first MMR vaccination among children in Finland.
Akseli A M Palmu, Heta Nieminen, Mika Lahdenkari, Arto A Palmu

Vaccine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection.
Nina Ekström, Anu Haveri, Anna Solastie, Camilla Virta, Pamela Österlund, Arto A Palmu

Open Forum Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination-statistical analysis plan.
Grant A Mackenzie, Arto A Palmu, Jukka Jokinen, Isaac Osei, Stefan Flasche

Trials· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron.
Ulrike Baum, Eero Poukka, Tuija Leino, Terhi Kilpi, Hanna Nohynek, Arto A Palmu

BMC Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCG.
Heta Nieminen, Mika Lahdenkari, Ritva K Syrjänen, Hanna Nohynek, Esa Ruokokoski, Arto A Palmu

Vaccine· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics.
Heta Nieminen, Tuovi Hakulinen, Taneli Puumalainen, Päivi Sirén, Arto A Palmu

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term population impact of infant 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in adults in Finland.
J Pekka Nuorti, Hanna Rinta-Kokko, Maija Toropainen, Lotta Siira, Hanna Nohynek, Arto A Palmu

Vaccine· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Antibiotic Use in Danish, Finnish, Norwegian and Swedish Children.
Nils Skajaa, Lise Gehrt, Heta Nieminen, Ida Laake, Hélène Englund, Arto A Palmu

Clin Epidemiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of trivalent influenza vaccines against hospitalizations due to laboratory-confirmed influenza a in the elderly: Comparison of test-negative design with register-based designs.
Jussi Halme, Ritva K Syrjänen, Ulrike Baum, Arto A Palmu

Vaccine· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020-2021.
Timothée Dub, Anna Solastie, Lotta Hagberg, Oona Liedes, Hanna Nohynek, Arto A Palmu

Front Med (Lausanne)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries.
Jacob Dag Berild, Vilde Bergstad Larsen, Emilia Myrup Thiesson, Toni Lehtonen, Mari Grøsland, Arto A Palmu

JAMA Netw Open· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects.
Anu Haveri, Anna Solastie, Nina Ekström, Pamela Österlund, Hanna Nohynek, Arto A Palmu

Eur J Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital Contacts for Infectious Diseases Among Children in Denmark, Finland, Norway, and Sweden, 2008-2017.
Lise Gehrt, Ida Laake, Hélène Englund, Heta Nieminen, Christine Stabell Benn, Arto A Palmu

Clin Epidemiol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial.
Grant A Mackenzie, Isaac Osei, Rasheed Salaudeen, Ilias Hossain, Benjamin Young, Arto A Palmu

Trials· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis